Burkina Faso vs Tajikistan: HIV-positive TB patients on ART (antiretroviral therapy)
Burkina Faso
100.0%
in 2024
Tajikistan
100.0%
in 2024
Burkina Faso rank
1st
Tajikistan rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Burkina Faso
- Tajikistan
How they compare
Burkina Faso currently reports 100.0% against 100.0% in Tajikistan, a difference of 0.0%.
The two have swapped places 7 times across 17 shared years of data; in 2007 it was Burkina Faso ahead.
Burkina Faso ranks 1st and Tajikistan ranks 1st of 144 countries.
Across the 3 decades both report, Burkina Faso averaged higher in 2 and Tajikistan in 1.
Head to head by decade
| Decade | Burkina Faso | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.7% | 36.0% | 14.7% | Burkina Faso |
| 2010s | 78.9% | 74.2% | 4.7% | Burkina Faso |
| 2020s | 94.2% | 97.8% | 3.6% | Tajikistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Burkina Faso or Tajikistan?
- Burkina Faso, at 100.0% against 100.0% in Tajikistan as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Burkina Faso and Tajikistan?
- 0.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Tajikistan?
- 17 years are reported by both, from 2007 to 2024.
- How do Burkina Faso and Tajikistan rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Burkina Faso ranks 1st and Tajikistan ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.